UNSPSC 51285503: Ditophal

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40SR2754GL. European Medicines Agency schedules Ditophal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06336MIG. Ditophal generally arises in the molecular formula C12H14O2S2. The term DITOPHAL is an International Non-Proprietary Name or INN. DITOPHAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule ditophal under HS 29309085 and SITC 51549. As of Q4 2014, DITOPHAL remains the US FDA Preferred Term for this commodity. Ditophal bears US NLM identifiers UMLS ID C1880369 and NCI Concept Code C65445. SMILES: CCSC(=O)C1=CC(=CC=C1)C(=O)SCC.

UNSPSC 51285503 Ditophal is a Commodity code under which state and local governments procure pharmaceutical products, including antibiotic tablets and opioid-reversal agents, for public health stockpiling and emergency response programs. The work spans piggyback purchasing through multistate consortia and direct county procurement for community health initiatives. Issuing bodies include state health departments and county governments with public health or emergency management mandates. Recent solicitations show state health departments leveraging cooperative purchasing vehicles to supply stockpiled pharmaceuticals at scale, while counties conduct direct competitive bidding for smaller volumes tied to specific health programs or emergency preparedness.

Activity under the code appears concentrated in Florida and Illinois based on recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (completed award, not open solicitation) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a 12-month initial term and two renewal options. Seminole County, Florida issued an IFB on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through its e-Procurement Portal, with quarterly deliveries to the Seminole County Community Health Building in Sanford, and a response deadline of July 26, 2023. Both opportunities required compliance with federal regulations when FEMA or cooperative purchasing applied, and both awarded on lowest-price-responsive-bidder criteria without explicit set-asides for disadvantaged businesses.